Biosmart Coltd Stock Cash And Equivalents
| 038460 Stock | KRW 5,490 50.00 0.90% |
BioSmart CoLtd fundamentals help investors to digest information that contributes to BioSmart CoLtd's financial success or failures. It also enables traders to predict the movement of BioSmart Stock. The fundamental analysis module provides a way to measure BioSmart CoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioSmart CoLtd stock.
BioSmart |
BioSmart CoLtd Company Cash And Equivalents Analysis
BioSmart CoLtd's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current BioSmart CoLtd Cash And Equivalents | 433.16 M |
Most of BioSmart CoLtd's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioSmart CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, BioSmart CoLtd has 433.16 M in Cash And Equivalents. This is much higher than that of the Technology Hardware, Storage & Peripherals sector and significantly higher than that of the Information Technology industry. The cash and equivalents for all Republic of Korea stocks is notably lower than that of the firm.
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
BioSmart Fundamentals
| Return On Equity | 2.28 | |||
| Return On Asset | 0.0086 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 153.4 B | |||
| Shares Outstanding | 19.98 M | |||
| Shares Owned By Insiders | 23.20 % | |||
| Shares Owned By Institutions | 1.07 % | |||
| Price To Earning | 79.80 X | |||
| Price To Sales | 0.33 X | |||
| Revenue | 189.18 B | |||
| Gross Profit | 58.91 B | |||
| EBITDA | 8.09 B | |||
| Net Income | 633.79 M | |||
| Cash And Equivalents | 433.16 M | |||
| Cash Per Share | 966.69 X | |||
| Total Debt | 33.07 B | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 1.50 X | |||
| Cash Flow From Operations | 2.33 B | |||
| Number Of Employees | 164 | |||
| Beta | 1.02 | |||
| Market Capitalization | 73.22 B | |||
| Total Asset | 225.85 B | |||
| Retained Earnings | 8.06 B | |||
| Working Capital | 6.46 B | |||
| Current Asset | 22.12 B | |||
| Current Liabilities | 15.66 B | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 225.85 B |
About BioSmart CoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioSmart CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioSmart CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioSmart CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioSmart CoLtd in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioSmart CoLtd's short interest history, or implied volatility extrapolated from BioSmart CoLtd options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioSmart CoLtd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the BioSmart CoLtd information on this page should be used as a complementary analysis to other BioSmart CoLtd's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for BioSmart Stock analysis
When running BioSmart CoLtd's price analysis, check to measure BioSmart CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioSmart CoLtd is operating at the current time. Most of BioSmart CoLtd's value examination focuses on studying past and present price action to predict the probability of BioSmart CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioSmart CoLtd's price. Additionally, you may evaluate how the addition of BioSmart CoLtd to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |